161 related articles for article (PubMed ID: 23695971)
21. Inhibition of cardiac Ca2+ release channels (RyR2) determines efficacy of class I antiarrhythmic drugs in catecholaminergic polymorphic ventricular tachycardia.
Hwang HS; Hasdemir C; Laver D; Mehra D; Turhan K; Faggioni M; Yin H; Knollmann BC
Circ Arrhythm Electrophysiol; 2011 Apr; 4(2):128-35. PubMed ID: 21270101
[TBL] [Abstract][Full Text] [Related]
22. Mexiletine block of wild-type and inactivation-deficient human skeletal muscle hNav1.4 Na+ channels.
Wang GK; Russell C; Wang SY
J Physiol; 2004 Feb; 554(Pt 3):621-33. PubMed ID: 14608007
[TBL] [Abstract][Full Text] [Related]
23. State-dependent trapping of flecainide in the cardiac sodium channel.
Ramos E; O'leary ME
J Physiol; 2004 Oct; 560(Pt 1):37-49. PubMed ID: 15272045
[TBL] [Abstract][Full Text] [Related]
24. Gating-dependent mechanisms for flecainide action in SCN5A-linked arrhythmia syndromes.
Viswanathan PC; Bezzina CR; George AL; Roden DM; Wilde AA; Balser JR
Circulation; 2001 Sep; 104(10):1200-5. PubMed ID: 11535580
[TBL] [Abstract][Full Text] [Related]
25. A distinct molecular mechanism by which phenytoin rescues a novel long QT 3 variant.
Gando I; Campana C; Tan RB; Cecchin F; Sobie EA; Coetzee WA
J Mol Cell Cardiol; 2020 Jul; 144():1-11. PubMed ID: 32339567
[TBL] [Abstract][Full Text] [Related]
26. Selectivity problems with drugs acting on cardiac Na⁺ and Ca²⁺ channels.
Hegyi B; Komáromi I; Nánási PP; Szentandrássy N
Curr Med Chem; 2013; 20(20):2552-71. PubMed ID: 23597201
[TBL] [Abstract][Full Text] [Related]
27. Antiarrhythmic effects of (-)-epicatechin-3-gallate, a novel sodium channel agonist in cultured neonatal rat ventricular myocytes.
Wu AZ; Loh SH; Cheng TH; Lu HH; Lin CI
Biochem Pharmacol; 2013 Jan; 85(1):69-80. PubMed ID: 23116965
[TBL] [Abstract][Full Text] [Related]
28. The cardiac sodium current Na(v)1.5 is functionally expressed in rabbit bronchial smooth muscle cells.
Bradley E; Webb TI; Hollywood MA; Sergeant GP; McHale NG; Thornbury KD
Am J Physiol Cell Physiol; 2013 Aug; 305(4):C427-35. PubMed ID: 23784541
[TBL] [Abstract][Full Text] [Related]
29. Preferential block of inactivation-deficient Na+ currents by capsaicin reveals a non-TRPV1 receptor within the Na+ channel.
Wang SY; Mitchell J; Wang GK
Pain; 2007 Jan; 127(1-2):73-83. PubMed ID: 16962240
[TBL] [Abstract][Full Text] [Related]
30. Tryptophan substitution of a putative D4S6 gating hinge alters slow inactivation in cardiac sodium channels.
Wang SY; Russell C; Wang GK
Biophys J; 2005 Jun; 88(6):3991-9. PubMed ID: 15805167
[TBL] [Abstract][Full Text] [Related]
31. Blocking effect of methylflavonolamine on human Na(V)1.5 channels expressed in Xenopus laevis oocytes and on sodium currents in rabbit ventricular myocytes.
Fan XR; Ma JH; Zhang PH; Xing JL
Acta Pharmacol Sin; 2010 Mar; 31(3):297-306. PubMed ID: 20173760
[TBL] [Abstract][Full Text] [Related]
32. The human Nav1.5 F1486 deletion associated with long QT syndrome leads to impaired sodium channel inactivation and reduced lidocaine sensitivity.
Song W; Xiao Y; Chen H; Ashpole NM; Piekarz AD; Ma P; Hudmon A; Cummins TR; Shou W
J Physiol; 2012 Oct; 590(20):5123-39. PubMed ID: 22826127
[TBL] [Abstract][Full Text] [Related]
33. Molecular basis of ranolazine block of LQT-3 mutant sodium channels: evidence for site of action.
Fredj S; Sampson KJ; Liu H; Kass RS
Br J Pharmacol; 2006 May; 148(1):16-24. PubMed ID: 16520744
[TBL] [Abstract][Full Text] [Related]
34. A revised view of cardiac sodium channel "blockade" in the long-QT syndrome.
Kambouris NG; Nuss HB; Johns DC; Marbán E; Tomaselli GF; Balser JR
J Clin Invest; 2000 Apr; 105(8):1133-40. PubMed ID: 10772658
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the effects of antiarrhythmic drugs flecainide and verapamil on fKv1.4ΔN channel currents in Xenopus oocytes.
Chen H; Zhang D; Chao SP; Ren JH; Xu L; Jiang XJ; Wang SM
Acta Pharmacol Sin; 2013 Feb; 34(2):221-30. PubMed ID: 23202797
[TBL] [Abstract][Full Text] [Related]
36. Class Ic antiarrhythmics block human skeletal muscle Na channel during myotonia-like stimulation.
Aoike F; Takahashi MP; Sakoda S
Eur J Pharmacol; 2006 Feb; 532(1-2):24-31. PubMed ID: 16473348
[TBL] [Abstract][Full Text] [Related]
37. Block of inactivation-deficient Na+ channels by local anesthetics in stably transfected mammalian cells: evidence for drug binding along the activation pathway.
Wang SY; Mitchell J; Moczydlowski E; Wang GK
J Gen Physiol; 2004 Dec; 124(6):691-701. PubMed ID: 15545401
[TBL] [Abstract][Full Text] [Related]
38. β1 and β3 subunits amplify mechanosensitivity of the cardiac voltage-gated sodium channel Nav1.5.
Maroni M; Körner J; Schüttler J; Winner B; Lampert A; Eberhardt E
Pflugers Arch; 2019 Dec; 471(11-12):1481-1492. PubMed ID: 31728700
[TBL] [Abstract][Full Text] [Related]
39. The effects of class Ic antiarrhythmics on tetrodotoxin-resistant Na+ currents in rat sensory neurons.
Osawa Y; Oda A; Iida H; Tanahashi S; Dohi S
Anesth Analg; 2004 Aug; 99(2):464-71, table of contents. PubMed ID: 15271726
[TBL] [Abstract][Full Text] [Related]
40. Differential regulation of tefluthrin and telmisartan on the gating charges of I
So EC; Wu SN; Lo YC; Su K
Toxicol Lett; 2018 Mar; 285():104-112. PubMed ID: 29306026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
